Myasthenia gravis drugs

These companies make drugs for myasthenia gravis and similar diseases where antibodies attack nerves.
−21.5%
over 3 months · S&P 500 −2.1%

Key indicators

Health
53 / 100
Fragile
Solid
Up over 1 year
6 of 7
Volatility
60%
Calm
Choppy
Profitability
−42%
Low
High
Health and price: against the other tags.